+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Oral Thin Films - Global Market Trajectory & Analytics

  • ID: 5309860
  • Report
  • April 2021
  • Region: Global
  • 184 pages
  • Global Industry Analysts, Inc
Global Oral Thin Films Market to Reach $5.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Oral Thin Films estimated at US$2.6 Billion in the year 2020, is projected to reach a revised size of US$5.9 Billion by 2027, growing at a CAGR of 12.3% over the period 2020-2027. Sublingual Film, one of the segments analyzed in the report, is projected to record 11.6% CAGR and reach US$2.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Fast Dissolving Dental/Buccal Film segment is readjusted to a revised 12.8% CAGR for the next 7-year period.



The U.S. Market is Estimated at $772.3 Million, While China is Forecast to Grow at 11.9% CAGR

The Oral Thin Films market in the U.S. is estimated at US$772.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2027 trailing a CAGR of 11.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.8% and 10.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9% CAGR.

Select Competitors (Total 48 Featured):
  • Allergan plc
  • Aquestive Therapeutics Inc.
  • Indivior plc
  • IntelGenx Corp.
  • LTS Lohmann Therapie-Systeme AG
  • Mylan NV
  • NAL Pharma
  • Novartis AG
  • Pfizer, Inc.
  • Solvay
  • Sumitomo Dainippon Pharma Co., Ltd.
  • ZIM Laboratories Limited
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Oral Thin Films by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Oral Thin Films by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Sublingual Film by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Sublingual Film by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Fast Dissolving Dental/Buccal Film by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Fast Dissolving Dental/Buccal Film by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Schizophrenia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Schizophrenia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 11: World Current & Future Analysis for Opioid Dependence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 12: World 7-Year Perspective for Opioid Dependence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 13: World Current & Future Analysis for Nausea & Vomiting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 14: World 7-Year Perspective for Nausea & Vomiting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 15: World Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 16: World 7-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 17: World Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 18: World 7-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 19: World Current & Future Analysis for Drug Store by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 20: World 7-Year Perspective for Drug Store by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 21: World Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 22: World 7-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 23: World Current & Future Analysis for E-Commerce by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 24: World 7-Year Perspective for E-Commerce by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
III. MARKET ANALYSIS
  • UNITED STATES
  • Table 25: USA Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 26: USA 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
  • Table 27: USA Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 28: USA 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
  • Table 29: USA Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 30: USA 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
  • CANADA
  • Table 31: Canada Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 32: Canada 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
  • Table 33: Canada Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 34: Canada 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
  • Table 35: Canada Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 36: Canada 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
  • JAPAN
  • Table 37: Japan Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 38: Japan 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
  • Table 39: Japan Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 40: Japan 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
  • Table 41: Japan Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 42: Japan 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
  • CHINA
  • Table 43: China Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 44: China 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
  • Table 45: China Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 46: China 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
  • Table 47: China Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 48: China 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
  • EUROPE
  • Table 49: Europe Current & Future Analysis for Oral Thin Films by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 50: Europe 7-Year Perspective for Oral Thin Films by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 51: Europe Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 52: Europe 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
  • Table 53: Europe Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 54: Europe 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
  • Table 55: Europe Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 56: Europe 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
  • FRANCE
  • Table 57: France Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 58: France 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
  • Table 59: France Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 60: France 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
  • Table 61: France Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 62: France 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
  • GERMANY
  • Table 63: Germany Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 64: Germany 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
  • Table 65: Germany Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 66: Germany 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
  • Table 67: Germany Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 68: Germany 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
  • ITALY
  • Table 69: Italy Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 70: Italy 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
  • Table 71: Italy Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 72: Italy 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
  • Table 73: Italy Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 74: Italy 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
  • UNITED KINGDOM
  • Table 75: UK Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 76: UK 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
  • Table 77: UK Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 78: UK 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
  • Table 79: UK Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 80: UK 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
  • REST OF EUROPE
  • Table 81: Rest of Europe Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 82: Rest of Europe 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
  • Table 83: Rest of Europe Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 84: Rest of Europe 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
  • Table 85: Rest of Europe Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 86: Rest of Europe 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
  • ASIA-PACIFIC
  • Table 87: Asia-Pacific Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 88: Asia-Pacific 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
  • Table 89: Asia-Pacific Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 90: Asia-Pacific 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
  • Table 91: Asia-Pacific Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 92: Asia-Pacific 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
  • REST OF WORLD
  • Table 93: Rest of World Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 94: Rest of World 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
  • Table 95: Rest of World Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 96: Rest of World 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
  • Table 97: Rest of World Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 98: Rest of World 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 48
Note: Product cover images may vary from those shown
Adroll
adroll